Elizabeth Austen Lawson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oxytocin | 37 | 2025 | 404 | 13.170 |
Why?
|
Anorexia Nervosa | 50 | 2024 | 1328 | 7.590 |
Why?
|
Appetite | 12 | 2024 | 247 | 3.880 |
Why?
|
Eating | 17 | 2024 | 1539 | 2.890 |
Why?
|
Ghrelin | 10 | 2024 | 255 | 2.150 |
Why?
|
Peptide YY | 6 | 2024 | 135 | 2.140 |
Why?
|
Hypopituitarism | 5 | 2025 | 253 | 1.640 |
Why?
|
Postprandial Period | 6 | 2024 | 320 | 1.600 |
Why?
|
Fasting | 9 | 2024 | 1606 | 1.590 |
Why?
|
Bone Density | 20 | 2023 | 3491 | 1.500 |
Why?
|
Administration, Intranasal | 8 | 2024 | 482 | 1.450 |
Why?
|
Appetite Regulation | 2 | 2021 | 84 | 1.370 |
Why?
|
Amenorrhea | 9 | 2017 | 470 | 1.330 |
Why?
|
Thinness | 7 | 2024 | 482 | 1.320 |
Why?
|
Obesity | 22 | 2024 | 13082 | 1.300 |
Why?
|
Body Composition | 9 | 2024 | 2441 | 1.190 |
Why?
|
Feeding Behavior | 12 | 2023 | 3209 | 1.180 |
Why?
|
Overweight | 9 | 2021 | 2444 | 1.160 |
Why?
|
Body Weight | 17 | 2023 | 4627 | 1.160 |
Why?
|
Motivation | 7 | 2024 | 2018 | 0.920 |
Why?
|
Cholecystokinin | 2 | 2022 | 114 | 0.900 |
Why?
|
Leptin | 9 | 2023 | 1596 | 0.880 |
Why?
|
Vasopressins | 2 | 2024 | 359 | 0.820 |
Why?
|
Energy Metabolism | 7 | 2024 | 2894 | 0.790 |
Why?
|
Hydrocortisone | 6 | 2015 | 1832 | 0.760 |
Why?
|
Hypothalamo-Hypophyseal System | 4 | 2019 | 702 | 0.750 |
Why?
|
Endocrine System Diseases | 2 | 2022 | 244 | 0.740 |
Why?
|
Food | 3 | 2023 | 764 | 0.740 |
Why?
|
Psychopathology | 6 | 2023 | 434 | 0.700 |
Why?
|
Cross-Sectional Studies | 34 | 2023 | 26282 | 0.700 |
Why?
|
Diabetes Insipidus, Neurogenic | 1 | 2020 | 20 | 0.690 |
Why?
|
Young Adult | 55 | 2024 | 59857 | 0.680 |
Why?
|
Appetitive Behavior | 1 | 2019 | 39 | 0.670 |
Why?
|
Pituitary-Adrenal System | 3 | 2015 | 553 | 0.670 |
Why?
|
Comorbidity | 7 | 2024 | 10575 | 0.670 |
Why?
|
Hip | 3 | 2017 | 249 | 0.650 |
Why?
|
Diabetes Insipidus | 1 | 2019 | 143 | 0.630 |
Why?
|
Body Dysmorphic Disorders | 2 | 2019 | 242 | 0.620 |
Why?
|
Menstruation | 3 | 2019 | 310 | 0.600 |
Why?
|
Energy Intake | 5 | 2024 | 2141 | 0.590 |
Why?
|
Affective Symptoms | 2 | 2017 | 417 | 0.580 |
Why?
|
Weight Loss | 5 | 2024 | 2710 | 0.580 |
Why?
|
Hypothalamus | 6 | 2025 | 1005 | 0.580 |
Why?
|
Pelvic Bones | 1 | 2020 | 273 | 0.570 |
Why?
|
Adolescent | 52 | 2024 | 88811 | 0.560 |
Why?
|
Body Mass Index | 17 | 2024 | 13042 | 0.550 |
Why?
|
Visual Perception | 3 | 2021 | 1393 | 0.540 |
Why?
|
Spine | 5 | 2017 | 1132 | 0.530 |
Why?
|
Anorexia | 2 | 2014 | 153 | 0.530 |
Why?
|
Diet, Sodium-Restricted | 1 | 2018 | 291 | 0.530 |
Why?
|
Receptors, Oxytocin | 1 | 2016 | 71 | 0.530 |
Why?
|
Metabolism | 1 | 2017 | 193 | 0.520 |
Why?
|
Female | 90 | 2025 | 396141 | 0.500 |
Why?
|
Adult | 73 | 2025 | 223088 | 0.490 |
Why?
|
Angiotensin II | 1 | 2018 | 844 | 0.490 |
Why?
|
Cross-Over Studies | 6 | 2025 | 2108 | 0.480 |
Why?
|
Sodium, Dietary | 1 | 2018 | 426 | 0.470 |
Why?
|
Appetite Depressants | 1 | 2015 | 108 | 0.470 |
Why?
|
Humans | 118 | 2025 | 765926 | 0.460 |
Why?
|
Hormones | 2 | 2009 | 865 | 0.460 |
Why?
|
Satiation | 3 | 2022 | 84 | 0.460 |
Why?
|
Maternal Behavior | 1 | 2016 | 307 | 0.460 |
Why?
|
Object Attachment | 1 | 2017 | 327 | 0.460 |
Why?
|
Psychotropic Drugs | 2 | 2017 | 880 | 0.450 |
Why?
|
Subcutaneous Fat | 1 | 2017 | 401 | 0.440 |
Why?
|
Anxiety | 7 | 2023 | 4669 | 0.430 |
Why?
|
Hunger | 4 | 2021 | 207 | 0.430 |
Why?
|
Binge-Eating Disorder | 3 | 2022 | 156 | 0.420 |
Why?
|
Bone and Bones | 3 | 2014 | 2555 | 0.410 |
Why?
|
Neuropeptides | 1 | 2018 | 952 | 0.410 |
Why?
|
Intra-Abdominal Fat | 1 | 2017 | 624 | 0.390 |
Why?
|
Executive Function | 2 | 2017 | 1391 | 0.390 |
Why?
|
Bone Diseases, Metabolic | 2 | 2012 | 407 | 0.380 |
Why?
|
Hypothalamic Diseases | 2 | 2009 | 132 | 0.370 |
Why?
|
Double-Blind Method | 9 | 2024 | 12417 | 0.340 |
Why?
|
Reward | 4 | 2023 | 980 | 0.320 |
Why?
|
Hemangiopericytoma | 1 | 2009 | 71 | 0.310 |
Why?
|
Homeostasis | 1 | 2019 | 3338 | 0.300 |
Why?
|
Brain | 7 | 2024 | 27179 | 0.300 |
Why?
|
Blood Glucose | 3 | 2019 | 6422 | 0.290 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2009 | 271 | 0.290 |
Why?
|
Male | 40 | 2025 | 363815 | 0.290 |
Why?
|
Social Support | 1 | 2017 | 2190 | 0.280 |
Why?
|
Sodium | 1 | 2012 | 1591 | 0.280 |
Why?
|
Genomic Imprinting | 1 | 2009 | 326 | 0.280 |
Why?
|
Weight Gain | 7 | 2023 | 2356 | 0.270 |
Why?
|
Adipose Tissue | 5 | 2024 | 3314 | 0.270 |
Why?
|
Athletes | 4 | 2017 | 1162 | 0.270 |
Why?
|
Depression | 6 | 2019 | 8223 | 0.270 |
Why?
|
Child | 23 | 2024 | 80568 | 0.270 |
Why?
|
Polymorphism, Genetic | 1 | 2016 | 4249 | 0.260 |
Why?
|
Amygdala | 5 | 2023 | 1376 | 0.260 |
Why?
|
Bone Diseases | 1 | 2009 | 411 | 0.260 |
Why?
|
Carotid Artery, Internal | 1 | 2008 | 440 | 0.260 |
Why?
|
Case-Control Studies | 10 | 2022 | 22228 | 0.250 |
Why?
|
Arteriovenous Fistula | 1 | 2008 | 318 | 0.250 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2007 | 357 | 0.250 |
Why?
|
Depressive Disorder | 3 | 2016 | 3712 | 0.250 |
Why?
|
Osteoporosis | 2 | 2012 | 1582 | 0.240 |
Why?
|
Severity of Illness Index | 7 | 2024 | 15878 | 0.240 |
Why?
|
Human Growth Hormone | 4 | 2017 | 639 | 0.230 |
Why?
|
Calorimetry, Indirect | 2 | 2015 | 176 | 0.230 |
Why?
|
Cerebral Cortex | 4 | 2014 | 5765 | 0.220 |
Why?
|
Magnetic Resonance Imaging | 13 | 2024 | 36547 | 0.220 |
Why?
|
Testosterone | 6 | 2019 | 2495 | 0.220 |
Why?
|
Glycopeptides | 1 | 2024 | 225 | 0.210 |
Why?
|
Absorptiometry, Photon | 8 | 2017 | 1707 | 0.210 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2025 | 362 | 0.210 |
Why?
|
Insulin-Like Growth Factor I | 4 | 2015 | 1936 | 0.210 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 4 | 2021 | 1987 | 0.210 |
Why?
|
Social Perception | 2 | 2019 | 435 | 0.210 |
Why?
|
Adiposity | 3 | 2024 | 1891 | 0.210 |
Why?
|
Pica | 2 | 2022 | 37 | 0.200 |
Why?
|
Dyspepsia | 1 | 2023 | 115 | 0.200 |
Why?
|
Radius | 2 | 2017 | 440 | 0.200 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15645 | 0.200 |
Why?
|
Hypoglycemia | 1 | 2009 | 896 | 0.190 |
Why?
|
Middle Aged | 27 | 2025 | 223016 | 0.190 |
Why?
|
Circadian Rhythm | 1 | 2013 | 2594 | 0.190 |
Why?
|
Prader-Willi Syndrome | 1 | 2022 | 80 | 0.190 |
Why?
|
Trust | 2 | 2018 | 532 | 0.170 |
Why?
|
Retrospective Studies | 13 | 2023 | 81537 | 0.170 |
Why?
|
Fibronectins | 2 | 2014 | 720 | 0.170 |
Why?
|
Brain Mapping | 4 | 2024 | 6598 | 0.170 |
Why?
|
Bulimia | 1 | 2022 | 405 | 0.160 |
Why?
|
Arginine Vasopressin | 1 | 2019 | 125 | 0.160 |
Why?
|
Craniopharyngioma | 1 | 2022 | 276 | 0.160 |
Why?
|
Diet, Protein-Restricted | 1 | 2019 | 73 | 0.160 |
Why?
|
Pituitary Gland | 1 | 2021 | 633 | 0.150 |
Why?
|
Feeding and Eating Disorders of Childhood | 1 | 2018 | 42 | 0.150 |
Why?
|
Bone Resorption | 2 | 2013 | 717 | 0.150 |
Why?
|
Androstane-3,17-diol | 1 | 2017 | 20 | 0.150 |
Why?
|
Impulsive Behavior | 1 | 2020 | 344 | 0.150 |
Why?
|
Hyperprolactinemia | 2 | 2009 | 122 | 0.150 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5784 | 0.140 |
Why?
|
Reference Values | 4 | 2019 | 4909 | 0.140 |
Why?
|
Insulin Resistance | 2 | 2024 | 3988 | 0.140 |
Why?
|
Cognition | 4 | 2023 | 7043 | 0.140 |
Why?
|
Vegetables | 2 | 2021 | 1200 | 0.140 |
Why?
|
Treatment Outcome | 7 | 2024 | 65194 | 0.140 |
Why?
|
Oligomenorrhea | 1 | 2017 | 42 | 0.140 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2019 | 6013 | 0.140 |
Why?
|
Pregnanolone | 1 | 2017 | 67 | 0.140 |
Why?
|
Fast Foods | 1 | 2019 | 220 | 0.140 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2009 | 238 | 0.140 |
Why?
|
Adolescent Development | 1 | 2020 | 273 | 0.140 |
Why?
|
Nutritive Value | 1 | 2019 | 350 | 0.130 |
Why?
|
Bulimia Nervosa | 1 | 2018 | 208 | 0.130 |
Why?
|
Lipolysis | 1 | 2017 | 211 | 0.130 |
Why?
|
Verbal Learning | 2 | 2017 | 459 | 0.130 |
Why?
|
C-Reactive Protein | 2 | 2024 | 3851 | 0.130 |
Why?
|
Exercise | 1 | 2013 | 5936 | 0.130 |
Why?
|
Radioimmunoassay | 3 | 2010 | 860 | 0.130 |
Why?
|
Cues | 1 | 2021 | 876 | 0.130 |
Why?
|
Social Behavior | 3 | 2019 | 1143 | 0.120 |
Why?
|
Mental Recall | 2 | 2017 | 1217 | 0.120 |
Why?
|
Reaction Time | 2 | 2020 | 2085 | 0.120 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2019 | 606 | 0.120 |
Why?
|
Facial Expression | 1 | 2019 | 514 | 0.120 |
Why?
|
Pituitary Neoplasms | 2 | 2022 | 1322 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 18074 | 0.120 |
Why?
|
Bariatric Surgery | 1 | 2024 | 997 | 0.120 |
Why?
|
Acromegaly | 1 | 2017 | 316 | 0.110 |
Why?
|
Dietary Proteins | 1 | 2019 | 960 | 0.110 |
Why?
|
Interpersonal Relations | 3 | 2018 | 1432 | 0.110 |
Why?
|
Weight-Bearing | 2 | 2015 | 529 | 0.110 |
Why?
|
Attitude | 1 | 2018 | 768 | 0.110 |
Why?
|
Child Behavior | 1 | 2019 | 864 | 0.110 |
Why?
|
Recombinant Proteins | 2 | 2015 | 6491 | 0.110 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2013 | 113 | 0.100 |
Why?
|
Hypothalamic Hormones | 1 | 2013 | 146 | 0.100 |
Why?
|
Pituitary Hormones | 1 | 2013 | 183 | 0.100 |
Why?
|
Animals | 7 | 2022 | 168735 | 0.100 |
Why?
|
Quality of Life | 3 | 2025 | 13463 | 0.100 |
Why?
|
Burnout, Professional | 1 | 2021 | 710 | 0.100 |
Why?
|
Oligopeptides | 1 | 2018 | 1193 | 0.100 |
Why?
|
Obesity, Morbid | 1 | 2023 | 1293 | 0.100 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14745 | 0.100 |
Why?
|
Judgment | 1 | 2014 | 270 | 0.100 |
Why?
|
Androgens | 2 | 2011 | 1278 | 0.090 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2013 | 618 | 0.090 |
Why?
|
Mechanical Phenomena | 1 | 2013 | 142 | 0.090 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2219 | 0.090 |
Why?
|
Sex Characteristics | 2 | 2014 | 2645 | 0.090 |
Why?
|
Etidronic Acid | 1 | 2011 | 63 | 0.090 |
Why?
|
Fibroblast Growth Factors | 2 | 2014 | 871 | 0.090 |
Why?
|
Adolescent Behavior | 1 | 2019 | 1184 | 0.090 |
Why?
|
Finite Element Analysis | 1 | 2013 | 441 | 0.090 |
Why?
|
Food Preferences | 1 | 2014 | 397 | 0.090 |
Why?
|
Estrogen Replacement Therapy | 1 | 2017 | 1206 | 0.090 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2015 | 597 | 0.080 |
Why?
|
Hyponatremia | 1 | 2012 | 278 | 0.080 |
Why?
|
Administration, Cutaneous | 3 | 2019 | 712 | 0.080 |
Why?
|
Phobic Disorders | 1 | 2012 | 440 | 0.080 |
Why?
|
Dietary Fats | 1 | 2017 | 2002 | 0.080 |
Why?
|
Skin Neoplasms | 1 | 2009 | 5836 | 0.080 |
Why?
|
Social Marketing | 1 | 2009 | 51 | 0.080 |
Why?
|
Suicidal Ideation | 1 | 2019 | 1465 | 0.080 |
Why?
|
Ergolines | 1 | 2009 | 55 | 0.080 |
Why?
|
Hormone Replacement Therapy | 1 | 2015 | 752 | 0.080 |
Why?
|
Pituitary Function Tests | 1 | 2008 | 24 | 0.080 |
Why?
|
Contraceptives, Oral | 2 | 2009 | 559 | 0.080 |
Why?
|
Hip Fractures | 3 | 2014 | 995 | 0.080 |
Why?
|
Poverty | 1 | 2021 | 2714 | 0.080 |
Why?
|
Anthropometry | 1 | 2013 | 1339 | 0.080 |
Why?
|
Spinal Fractures | 1 | 2015 | 702 | 0.080 |
Why?
|
Body Height | 1 | 2015 | 1561 | 0.080 |
Why?
|
Age Factors | 3 | 2019 | 18382 | 0.070 |
Why?
|
Dehydroepiandrosterone | 1 | 2009 | 248 | 0.070 |
Why?
|
Pilot Projects | 2 | 2018 | 8724 | 0.070 |
Why?
|
Cerebrovascular Circulation | 1 | 2017 | 2674 | 0.070 |
Why?
|
Heart Valves | 1 | 2009 | 284 | 0.070 |
Why?
|
Tibia | 1 | 2013 | 1064 | 0.070 |
Why?
|
Adrenal Insufficiency | 1 | 2008 | 194 | 0.070 |
Why?
|
Hyperthyroidism | 1 | 2008 | 292 | 0.070 |
Why?
|
Restaurants | 1 | 2009 | 235 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3230 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2012 | 2350 | 0.060 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2007 | 187 | 0.060 |
Why?
|
Oxygen | 1 | 2017 | 4246 | 0.060 |
Why?
|
Thyroid Hormones | 1 | 2008 | 408 | 0.060 |
Why?
|
Glucose | 1 | 2017 | 4335 | 0.060 |
Why?
|
Body Image | 1 | 2010 | 645 | 0.060 |
Why?
|
RNA, Untranslated | 1 | 2009 | 454 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2010 | 6202 | 0.060 |
Why?
|
Anxiety Disorders | 1 | 2016 | 2739 | 0.060 |
Why?
|
Insulin | 3 | 2015 | 6603 | 0.060 |
Why?
|
Area Under Curve | 1 | 2009 | 1637 | 0.060 |
Why?
|
Amyloid | 1 | 2009 | 848 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2013 | 1881 | 0.060 |
Why?
|
Prospective Studies | 4 | 2024 | 54807 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10843 | 0.060 |
Why?
|
Lipoproteins, LDL | 1 | 2007 | 643 | 0.060 |
Why?
|
Bone Density Conservation Agents | 1 | 2011 | 791 | 0.050 |
Why?
|
Health Promotion | 2 | 2021 | 2208 | 0.050 |
Why?
|
Angiography | 1 | 2008 | 1589 | 0.050 |
Why?
|
Fractures, Bone | 1 | 2015 | 2041 | 0.050 |
Why?
|
Lipoproteins, HDL | 1 | 2007 | 676 | 0.050 |
Why?
|
Diet | 2 | 2018 | 8087 | 0.050 |
Why?
|
Phonetics | 1 | 1984 | 207 | 0.050 |
Why?
|
Genotype | 1 | 2016 | 13026 | 0.050 |
Why?
|
Neural Pathways | 3 | 2019 | 3087 | 0.050 |
Why?
|
Fetus | 1 | 2009 | 1878 | 0.050 |
Why?
|
Single-Blind Method | 1 | 2025 | 1587 | 0.050 |
Why?
|
Saline Solution, Hypertonic | 1 | 2021 | 116 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2023 | 5300 | 0.040 |
Why?
|
Time Factors | 3 | 2018 | 40097 | 0.040 |
Why?
|
Treatment Failure | 2 | 2019 | 2653 | 0.040 |
Why?
|
Up-Regulation | 1 | 2009 | 4130 | 0.040 |
Why?
|
Mental Disorders | 1 | 2019 | 6870 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2688 | 0.040 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2021 | 216 | 0.040 |
Why?
|
Tryptophan | 1 | 2021 | 483 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9443 | 0.040 |
Why?
|
Glucocorticoids | 1 | 2008 | 2155 | 0.040 |
Why?
|
Speech Perception | 1 | 1984 | 512 | 0.040 |
Why?
|
Signal Transduction | 2 | 2019 | 23597 | 0.040 |
Why?
|
Ventral Tegmental Area | 1 | 2019 | 136 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2009 | 4882 | 0.040 |
Why?
|
Appetite Stimulants | 1 | 2018 | 14 | 0.040 |
Why?
|
Gastrectomy | 1 | 2023 | 693 | 0.040 |
Why?
|
Immunity | 1 | 2024 | 1000 | 0.040 |
Why?
|
Risk Factors | 4 | 2019 | 74850 | 0.040 |
Why?
|
Health Behavior | 1 | 2009 | 2649 | 0.040 |
Why?
|
Arginine | 1 | 2021 | 931 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2007 | 3225 | 0.030 |
Why?
|
Mass Screening | 1 | 2012 | 5449 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2021 | 1366 | 0.030 |
Why?
|
Gastric Emptying | 1 | 2018 | 247 | 0.030 |
Why?
|
Fruit | 1 | 2021 | 1167 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2353 | 0.030 |
Why?
|
Femur | 2 | 2014 | 1309 | 0.030 |
Why?
|
Acylation | 1 | 2014 | 98 | 0.030 |
Why?
|
Memory | 1 | 1984 | 2191 | 0.030 |
Why?
|
Estradiol | 2 | 2012 | 1947 | 0.030 |
Why?
|
Prevalence | 2 | 2021 | 15828 | 0.030 |
Why?
|
Progesterone | 1 | 2017 | 751 | 0.030 |
Why?
|
Indoles | 1 | 2021 | 1833 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2015 | 6306 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2009 | 8603 | 0.030 |
Why?
|
Self Administration | 1 | 2014 | 386 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2017 | 7116 | 0.030 |
Why?
|
Risk Assessment | 3 | 2019 | 24275 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39228 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4851 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2022 | 8107 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2018 | 2740 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20690 | 0.020 |
Why?
|
Osteoarthritis | 1 | 1978 | 1050 | 0.020 |
Why?
|
Islet Amyloid Polypeptide | 1 | 2009 | 41 | 0.020 |
Why?
|
Fear | 1 | 2018 | 1496 | 0.020 |
Why?
|
Outpatients | 1 | 2018 | 1595 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2020 | 2415 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 4016 | 0.020 |
Why?
|
Hormone Antagonists | 1 | 2009 | 108 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2010 | 393 | 0.020 |
Why?
|
Prolactinoma | 1 | 2009 | 114 | 0.020 |
Why?
|
Nerve Net | 1 | 2020 | 2310 | 0.020 |
Why?
|
Face | 1 | 2014 | 1029 | 0.020 |
Why?
|
Corpus Striatum | 1 | 2014 | 1218 | 0.020 |
Why?
|
Massachusetts | 2 | 2012 | 8882 | 0.020 |
Why?
|
Poverty Areas | 1 | 2009 | 268 | 0.020 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2010 | 557 | 0.020 |
Why?
|
Hippocampus | 1 | 2020 | 3772 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4248 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10727 | 0.020 |
Why?
|
Prolactin | 1 | 2009 | 625 | 0.020 |
Why?
|
Collagen Type I | 1 | 2010 | 616 | 0.020 |
Why?
|
Emotions | 1 | 2019 | 2759 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2009 | 59496 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10380 | 0.020 |
Why?
|
Rats | 1 | 2022 | 23708 | 0.020 |
Why?
|
Drug Utilization | 1 | 2012 | 1187 | 0.020 |
Why?
|
Photic Stimulation | 1 | 2012 | 1992 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1512 | 0.020 |
Why?
|
Child, Preschool | 2 | 2019 | 42510 | 0.010 |
Why?
|
Learning | 1 | 2014 | 1754 | 0.010 |
Why?
|
Prefrontal Cortex | 1 | 2014 | 2223 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 8924 | 0.010 |
Why?
|
Research Design | 1 | 2019 | 6204 | 0.010 |
Why?
|
Drug Prescriptions | 1 | 2012 | 1662 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9656 | 0.010 |
Why?
|
United States | 2 | 2021 | 72909 | 0.010 |
Why?
|
Self Concept | 1 | 2007 | 1039 | 0.010 |
Why?
|
Urban Population | 1 | 2009 | 2040 | 0.010 |
Why?
|
Evoked Potentials, Auditory | 1 | 1984 | 529 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20133 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2012 | 2901 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 41680 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2012 | 3075 | 0.010 |
Why?
|
Parietal Lobe | 1 | 1984 | 859 | 0.010 |
Why?
|
Frontal Lobe | 1 | 1984 | 1408 | 0.010 |
Why?
|
Echocardiography | 1 | 2009 | 5040 | 0.010 |
Why?
|
Prognosis | 1 | 2017 | 29890 | 0.010 |
Why?
|
Nigeria | 1 | 1978 | 782 | 0.010 |
Why?
|
Hip Dislocation | 1 | 1978 | 247 | 0.010 |
Why?
|
Arthritis, Infectious | 1 | 1978 | 347 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 14450 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2007 | 15401 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13631 | 0.000 |
Why?
|
Aged | 2 | 2009 | 171163 | 0.000 |
Why?
|
Mice | 1 | 2008 | 81782 | 0.000 |
Why?
|